abstract |
The present invention relates to the prophylactic treatment against, or therapeutic treatment of Th2-mediated diseases or disorders. Vaccines useful in these methods of treatment are provided. The vaccines comprise as active agent immunogenic acyl glyceryl phosphatidyinositol manno-oligosaccharide. |